Abiopharma

NORTHWEST BIOTHERAPEUTICS, INC. (NWBO)

Symbol	NWBO
Name	NORTHWEST BIOTHERAPEUTICS, INC.
Sector	UNDEFINED
Region	North America
Industry	-
Address	20814 United States MD 4800 Montgomery Lane Suite 800
Telephone	(240) 497-9024
Fax	—
Email	—
Website	http://www.nwbio.com
Incorporation	US
Incorporated On	1998
Employees	—
Fiscal Year	12/31
Public Since	—
Exchanges	OTC
Auditor	Cherry Bekaert LLP;
Audit Status	AUDITED
Reporting Status	U.S. Reporting: SEC Reporting
CIK	0001072379
Description	Northwest Biotherapeutics is a biotechnology company focused on developing personalized immunotherapy products that are designed to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis. The Company has a broad platform technology for DCVax® dendritic cell-based vaccines. The Companys lead program involves DCVax®-L treatment for glioblastoma (GBM). Additional info from OTC: Northwest Biotherapeutics is a biotechnology company focused on developing personalized immunotherapy products that are designed to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis. The Company has a broad platform technology for DCVax® dendritic cell-based vaccines. The Companys lead program involves DCVax®-L treatment for glioblastoma (GBM).

2026-04-30 16:47

Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform

2026-04-21 14:56

Northwest Biotherapeutics Announces Establishment Of the Company’s Own Dedicated Leukapheresis Clinic

2026-01-02 22:14

(99% Neutral) Northwest Biotherapeutics, Inc. (NWBO) Announces Regulatory Update

2025-11-28 21:44

New Form DEF 14A - NORTHWEST BIOTHERAPEUTICS INC Filed: 2025-11-28 AccNo: 0001104659-25-116966 Size: 2 MB

2025-11-25 22:23

New Form 424B5 - NORTHWEST BIOTHERAPEUTICS INC Filed: 2025-11-25 AccNo: 0001104659-25-116045 Size: 361 KB

2025-11-20 21:26

(99% Neutral) Northwest Biotherapeutics, Inc. (NWBO) Announces Business Combination

2025-11-20 20:10

Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK Facility

2025-11-19 21:16

New Form PRE 14A - NORTHWEST BIOTHERAPEUTICS INC Filed: 2025-11-19 AccNo: 0001104659-25-114107 Size: 2 MB

2025-11-14 21:46

Northwest Biotherapeutics, Inc. (NWBO) Files Form 10-Q

2025-11-05 20:39

Acer Predator Helios 500 17 AMD: Performance Review and 2026 Gaming Analysis